Tickerplace logo

Tickerplace

Entero Therapeutics, Inc. logo

ENTOEntero Therapeutics, Inc.

ENTO Stock Price, Valuation & Chart | Entero Therapeutics, Inc.

Compare
$2.850-0.15 (-5.00%)

At close · 29 Jan 2026, 02:30 pm

Sector: HealthcareIndustry: BiotechnologyENTO intrinsic valueENTO calculated fair value vs price
OverviewFinancialsDividendsRatios

ENTO Historical price chart

ENTO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization13.58M
PE Ratio-0.24
EPS-11.66
Trading Volume93.18K
Today's High/Low3.15/2.82
Dividend Yield0.00
52 Week High/Low5.84/0.97
Shares Outstanding4.77M
ENTO Financial Statement
ENTO Analyst ratings
ENTO Analysis & performance metrics

ENTO Company profile

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of…

ENTO Management team

Management
Anna SkowronCFO
Chief Financial Officer
Total 1 executive

ENTO Frequently asked questions

What is Entero Therapeutics, Inc. (ENTO) Stock Price?

Current stock price of Entero Therapeutics, Inc. (ENTO) stock is $2.850. The stock price is -5.00% lower in the session. The intraday range can be seen from this page. Volume of Entero Therapeutics, Inc. (ENTO) stock is 93.18K.

Last updated at 29 Jan 2026, 02:30 pm.

Why is the Entero Therapeutics, Inc. (ENTO) stock price going up or down today?

The stock price of Entero Therapeutics, Inc. (ENTO) can change with earnings, company news, and overall market sentiment. Entero Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Entero Therapeutics, Inc. stock expensive at its current price?

Whether Entero Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ENTO on this page is -0.24. EPS on this page is -11.66. Compare those figures with peers and growth expectations before deciding if the current Entero Therapeutics, Inc. price is justified.

How has the stock price of Entero Therapeutics, Inc. (ENTO) performed historically?

Historical performance for Entero Therapeutics, Inc. (ENTO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ENTO reacted to past earnings and market events.

Should I buy Entero Therapeutics, Inc. (ENTO) stock, at this price?

Buying Entero Therapeutics, Inc. (ENTO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.